Skip to main content

Table 1 Peptide sequences of  m/z  4223.1 determined from the LC-MS/MS analysis

From: Protective effect of the Japanese traditional medicine juzentaihoto on myelosuppression induced by the anticancer drug TS-1 and identification of a potential biomarker of this effect

A

Matched mass

Computed mass

Residues

Sequence

 

1735.8

1735.7

570-584

K.TVMDDFAQFLDTCCK. A

 

1751.7

1751.7

570-584

K.TVMDDFAQFLDTCCK.A Oxidation (M)

 

1923.9

1923.9

585-602

K.AADKDTCFSTEGPNLVTR.C

 

1995.0

1994.9

585-602

K.AADKDTCFSTEGPNLVTR.C Propionamide (C)

 

1538.7

1538.7

589-602

K.DTCFSTEGPNLVTR.C

B

551 TALAELVKHK PKATAEQLKT VMDDFAQFLD TCCKAADKDT CFSTEGPNLV

 

601 TR CKDALA

  1. A) Peptide sequences determined from LC-MS/MS analysis. B) Amino acid sequence of the C-terminal peptide (from residue 551 to 608) of mouse albumin (Swiss-Prot entry P07724). Matched peptides shown in Bold.